Literature DB >> 6292705

The binding and activation of the Clr-Cls subunit of the first component of human complement.

N C Hughes-Jones, B D Gorick.   

Abstract

The value of the functional affinity constant between 125I-labelled Clq and the Clr-Cls tetramer (when free in solution) in the formation of Cl was found to be 3.6 X 10(7) M-1. When Clq was bound to activating immune complexes, the value of K was about 10-fold higher before initiation of activation and there was a further two to three-fold rise as activation proceeded. The addition of an excess of unlabelled Clq increased the rate of activation of 125I-labelled Cl, suggesting an interaction between Clr-Cls and two neighbouring Clq molecules. It is suggested that the tetramer Clr-Cls may bind bivalently to Clq when free in solution, but on binding to activating complexes, one of the Clr-Cls binding sites is detached from Clq and becomes bound to a site on the complex. The resultant spatial rearrangement of the Clr molecules within the tetramer may be optimal for autocatalytic activation of Clr.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292705     DOI: 10.1016/0161-5890(82)90321-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Antibody-independent activation of the classical pathway of complement by Epstein-Barr virus.

Authors:  H Martin; I McConnell; B Gorick; N C Hughes-Jones
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

Review 2.  Methods to detect and quantitate complement activation.

Authors:  N R Cooper; G R Nemerow; J T Mayes
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Initiation of complement activation.

Authors:  P J Lachmann; N C Hughes-Jones
Journal:  Springer Semin Immunopathol       Date:  1984

Review 4.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

5.  Critical dependence on antibody for defence against mycoplasmas.

Authors:  A D Webster; P M Furr; N C Hughes-Jones; B D Gorick; D Taylor-Robinson
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.